Surgery Partners (SGRY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings ...

Shares of Surgery Partners, Inc. (NASDAQ:SGRY – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from ...

Cantor Fitzgerald reaffirmed its Overweight rating on Surgery Partners (NASDAQ:SGRY) with a steady price target of $36.00. The stock, which has shown significant momentum with a 20% return over the ...

Surgery Partners receives takeover bid from Bain Capital at $25.75 per share, sparking interest among potential buyers in the ...

Another notable valuation metric for SGRY is its P/B ratio of 1.27. The P/B ratio is used to compare a stock's market value with its book value, which is defined as total assets minus total ...

Check the time stamp on this data. Updated AI-Generated Signals for Surgery Partners Inc. (SGRY) available here: SGRY. Type a few symbols and Take a Trial. The signals for these will appear ...

Analyst Whit Mayo of Leerink Partners reiterated a Buy rating on Surgery Partners (SGRY – Research Report), with a price target of ...

Investors in Surgery Partners Inc (Symbol: SGRY) saw new options become available this week, for the September 19th expiration. One of the key data points that goes into the price an option buyer ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Surgery Partners (SGRY – Research Report) and Stryker (SYK – ...

Surgery Partners SGRY shares soared 21.2% in the last trading session to close at $25.75. The move was backed by solid volume with far more shares changing hands than in a normal session.